PhaseFolio
Sign in

Evidence,
connected.

PhaseFolio connects the scattered public record of life sciences into evidence you can trace. Every conclusion stays attached to the source it came from.

Sign upExplore the products
ClinicalTrials.govStudy recordNCT02296125officialTitleOfficial title, excerpt…Double-blind, Randomised…maskingInfo.maskingMasking, structured fieldTRIPLECTIS · beta, view onlyEU trial recordComparisonMasking, as recordedOfficial titleDouble-blind1Structured fieldTriple1Shown as captured
Representative illustration. Values from NCT02296125, retrieved 14 Sep 2026.

From scattered evidence to a shared point of view.

Different questions need different tools. Start with the landscape, develop the case, and help shape what comes next.

Bring the landscape into focus

Start with the question.
Not the spreadsheet.

Bring relevant trial records together. Turn scattered evidence into a comparison you can inspect, challenge, and carry into your next decision.

Explore Atlas
A landscape, connectedProduct illustration
Start with your question. Bring the relevant registry records into view.

Every claim keeps its source

Read what the record says. Then check it.

In the FLAURA registry record, the official title calls the study double-blind, while the structured masking field records triple masking.1 Atlas shows both values as captured and does not reconcile them.

FLAURA2’s structured masking field records none, and its official title describes the study as open-label.2

NCT02296125 · retrieved 14 Sep 2026
Official title, excerpt
A Phase III, Double-blind, Randomised Study to Assess the Safety and Efficacy of AZD9291…protocolSection.identificationModule.officialTitle
Masking, structured field
TRIPLE (participant, investigator, outcomes assessor)protocolSection.designModule.designInfo.maskingInfo.masking

Shown as captured. Not reconciled or reworded.

Keep the thread

Conviction comes from the connections.

A comparison is more useful when you can follow the evidence behind it. A scenario is easier to discuss when you can see the assumptions that change it.

PhaseFolio keeps that context close, so the next conversation can build on the work you have already done.

Find your starting point

The sources behind the landscape

A wider world of evidence.

Starting with ClinicalTrials.gov, and building toward a more connected view of trials, biology, publications and company context.

Available in AtlasClinicalTrials.gov

Trial records and study context, linked to the source.

See every source and its status

CTISBeta, view only

Where enabled, view European trial records from the EMA public portal. This beta is separate from activated comparison sources and does not support selection, evidence packets or model analysis. Check the source status in your account.

Planned sources

Not yet connected in Atlas. Shown as planned, without dates.
  • EUCTR / EudraCTHistorical European trial recordsPlanned
  • openFDAFDA public dataPlanned
  • EMAEuropean regulatory recordsPlanned
  • PubMedPublication records and citationsPlanned
  • Open TargetsTarget and disease contextPlanned
  • ChEMBLMolecules and mechanismsPlanned
  • SEC EDGARCompany filings and disclosuresPlanned
  • Company disclosuresPrimary company announcementsPlanned

Coverage expands as each source becomes available in Atlas.

Notes

  1. ClinicalTrials.gov, NCT02296125 (FLAURA), fields officialTitle and maskingInfo.masking. Retrieved 14 Sep 2026. View the record
  2. ClinicalTrials.gov, NCT04035486 (FLAURA2), fields officialTitle and maskingInfo.masking. Retrieved 14 Sep 2026. View the record
PhaseFolio and EB Research Partnership announcement

Featured Announcement · Nonprofit Access Program

PhaseFolio Begins Work With EB Research Partnership

EB Research Partnership will use PhaseFolio to examine valuation assumptions, compare scenarios, organize supporting evidence, and evaluate research programs at both the asset and portfolio level. Access is being provided on a complimentary basis through PhaseFolio’s nonprofit access program.

Read the Full Announcement

This collaboration supports internal evaluation and workflow feedback. It does not imply EB Research Partnership’s endorsement or independent validation of PhaseFolio’s methodologies or outputs.

Start with your next question.

Sign upContact sales

For organization-wide access or a larger workflow, talk to us.